Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors.
Saved in:
| Title: | Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors. |
|---|---|
| Authors: | Zeng ZX; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Song HC; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Li YN; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Wu JY; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China., Liang D; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China.; Department of General Surgery, Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, People's Republic of China., Li SQ; Department of Hepatobiliary Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Province, People's Republic of China., Zhang ZB; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Zhuang SW; Department of Interventional Radiology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, People's Republic of China., Li B; Department of Hepato-Biliary-Pancreatic and Vascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province, People's Republic of China., Zhou JY; Department of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian Province, People's Republic of China., Liu DY; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Li H; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Ou XY; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Pan RJ; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China., Wu JY; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China., Yan ML; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian Province, People's Republic of China. |
| Source: | The oncologist [Oncologist] 2025 Jun 04; Vol. 30 (6). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyaf058 |
